Syndax Pharmaceuticals (Germany) Price on December 17, 2024

1T3 Stock  EUR 12.10  0.30  2.42%   
If you're considering investing in Syndax Stock, it is important to understand the factors that can impact its price. As of today, the current price of Syndax Pharmaceuticals stands at 12.10, as last reported on the 21st of December, with the highest price reaching 12.10 and the lowest price hitting 12.10 during the day. Syndax Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0738, which indicates the firm had a -0.0738% return per unit of risk over the last 3 months. Syndax Pharmaceuticals exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Syndax Pharmaceuticals' Coefficient Of Variation of (1,248), risk adjusted performance of (0.06), and Variance of 18.84 to confirm the risk estimate we provide.
  
Syndax Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0738

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns1T3

Estimated Market Risk

 4.34
  actual daily
38
62% of assets are more volatile

Expected Return

 -0.32
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.07
  actual daily
0
Most of other assets perform better
Based on monthly moving average Syndax Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Syndax Pharmaceuticals by adding Syndax Pharmaceuticals to a well-diversified portfolio.

Syndax Pharmaceuticals Valuation on December 17, 2024

It is possible to determine the worth of Syndax Pharmaceuticals on a given historical date. On December 17, 2024 Syndax was worth 12.8 at the beginning of the trading date compared to the closed value of 12.8. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Syndax Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Syndax Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Syndax Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Syndax Pharmaceuticals' related companies.
 Open High Low Close Volume
  12.90    12.90    12.90    12.90    645.00  
12/17/2024
  12.80    12.80    12.80    12.80    645.00  
  12.70    12.70    12.70    12.70    645.00  
Backtest Syndax Pharmaceuticals  |  Syndax Pharmaceuticals History  |  Syndax Pharmaceuticals Valuation   PreviousNext  
Open Value
12.8
12.8
Closing Value
25.81
Upside

Syndax Pharmaceuticals Trading Date Momentum on December 17, 2024

On December 18 2024 Syndax Pharmaceuticals was traded for  12.70  at the closing time. The highest daily price throughout the period was 12.70  and the lowest price was  12.70 . The daily volume was 645. The net trading volume on 12/18/2024 added to the next day price reduction. The daily price change to closing price of the next trading day was 0.78% . The trading price change to current closing price is 5.47% .

Syndax Pharmaceuticals Fundamentals Correlations and Trends

By evaluating Syndax Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Syndax Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Syndax financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Syndax Pharmaceuticals Stock history

Syndax Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Syndax is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Syndax Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Syndax Pharmaceuticals stock prices may prove useful in developing a viable investing in Syndax Pharmaceuticals
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. The company was founded in 2005 and is headquartered in Waltham, Massachusetts. Syndax Pharmaceuticals operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 38 people.

Syndax Pharmaceuticals Stock Technical Analysis

Syndax Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Syndax Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Syndax Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Syndax Pharmaceuticals Period Price Range

Low
December 21, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Syndax Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on Frankfurt Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Syndax Pharmaceuticals December 21, 2024 Market Strength

Market strength indicators help investors to evaluate how Syndax Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Syndax Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Syndax Pharmaceuticals stock market strength indicators, traders can identify Syndax Pharmaceuticals entry and exit signals to maximize returns

Syndax Pharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Syndax Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Syndax Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Syndax to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Syndax Stock analysis

When running Syndax Pharmaceuticals' price analysis, check to measure Syndax Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Syndax Pharmaceuticals is operating at the current time. Most of Syndax Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Syndax Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Syndax Pharmaceuticals' price. Additionally, you may evaluate how the addition of Syndax Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Equity Valuation
Check real value of public entities based on technical and fundamental data
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like